The reduction in the 28-day mortality rate did not reach statistical significance.
← all excerpts
Efficacy and safety of short-acting β-blockers in patients with sepsis-associated cardiac dysfunction: a systematic review and meta-analysis of randomized controlled trials.
1
—
—